- 4-Week # shares bought: 4,000
- 12-Week # shares bought: 90,000
- 24-Week # shares bought: 90,000
Array BioPharma, Advaxis, Merrimack Pharmaceuticals and Insys Therapeutics were among the biotech stock movers in premarket trading on Tuesday.
The companies inked a $250 million deal on Friday that could be worth up to $2 billion, thanks to milestone payments.